
This episode explores the differences between behavior that is caught rather than taught, explaining how leadership can be a learned skill if properly approached.

This episode explores the differences between behavior that is caught rather than taught, explaining how leadership can be a learned skill if properly approached.

With value-based care initiatives on the rise in the US health care system, one partnership in Ohio is showing early signs of significant success.

In part 2, Kevin Day, PharmD, breaks down the Pharmacy Quality Rewards Program and its push toward value-based care in pharmacy practice.

Kevin Day, PharmD, provides insight into his role in the Pharmacist Quality Rewards Program and what it’s doing for patients in his community.

Utilizing colleges and schools of pharmacy, researchers explorensolutions to the growing challenges affecting community pharmacy.

Drug pricing rules reshape pharmacy and manufacturer strategies, as transparency grows and 340B reforms intensify scrutiny.

Among community pharmacies and their patients, researchers explore the power of protected learning time for improving services and outcomes.

With its capabilities improving rapidly in the health care space, technology and pharmacy experts discuss AI’s future place in pharmacy practice as further developments are released.

An exploration of community pharmacists’ perceptions of e-pharmacy, assessing whether they believe it’s a threat or benefit.

In this episode, host Taylor Watterson, PharmD, PhD, brings us a solo rendition breaking down some of her recent research with SCRPTS Laboratory.

In a recent webinar sponsored by Drug Topics, pharmacy and insurance industry experts discuss the true impact of recent PBM reform efforts on the greater drug supply chain.

In an evolving pharmacy landscape, accreditation can be difficult to manage, which is why experts like Mitch Lamb, PharmD, can steer businesses onto their desired paths.

This proposed rule builds on previous CMS guidance from 2020 and 2024.

New research examines what drives, or hinders, pharmacists when guiding patients through self-medication decisions for minor ailments like cold and flu.

In an exploration of pharmacists’ self-efficacy, researchers explored medication counseling outcomes for older adults across various languages.

Researchers conduct an exploration of e-prescription challenges and potential across pharmacies in Germany.

This episode highlights key DSCSA updates in 2026, T3 documentation going forward, and many more developments surrounding the law.

Researchers measure exactly how much pharmacist-provided care is being underbilled and what gaps mean for the future of reimbursement.

With a 7-year target date, the FDA is moving away from 10-digit NDCs and toward a universal 12-digit format.

Exploring both patient-level and organizational factors, researchers assess community pharmacy accessibility for immunizations and injectables.

In part 2, Neal Cooper and Matt Sample address the foreseeable challenges and necessary questions surrounding the FDA’s push toward 12-digit national drug codes.

Matt Sample and Neal Cooper join to discuss the beginning stages of the FDA’s 7-year rollout of new NDCs for prescription drugs.

This episode explores the gaps between pharmacy leaders and the communities, and patients, that they serve.

With workforce and work-life balance issues plaguing pharmacy, the newly introduced hybrid pharmacist role is creating innovation across the greater pharmacy industry.

In part 2 of our interview with Walgreens Chief Pharmacy Officer Rick Gates, he explored the modernization behind his organization’s newly introduced ‘hybrid pharmacist’ role.

Rick Gates, chief pharmacy officer at Walgreens, helps introduce his organization’s innovative new ‘hybrid pharmacist’ role.